Recurrent Respiratory Papillomatosis Therapy (Henderson Morley)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRecurrent Respiratory Papillomatosis Therapy (Henderson Morley)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitorsIon modulators
TargetsUpdating
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHenderson Morley plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHenderson Morley plc
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A